211 related articles for article (PubMed ID: 8539393)
1. Patterns of contrast enhancement in the pediatric spine at MR imaging with single- and triple-dose gadolinium.
Tam JK; Bradley WG; Goergen SK; Chen DY; Pema PJ; Dubin MD; Teresi LM; Jordan JE
Radiology; 1996 Jan; 198(1):273-8. PubMed ID: 8539393
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome: MR imaging findings of the spine in eight patients.
Byun WM; Park WK; Park BH; Ahn SH; Hwang MS; Chang JC
Radiology; 1998 Jul; 208(1):137-41. PubMed ID: 9646804
[TBL] [Abstract][Full Text] [Related]
3. Spinal cord ependymomas: MR imaging features.
Fine MJ; Kricheff II; Freed D; Epstein FJ
Radiology; 1995 Dec; 197(3):655-8. PubMed ID: 7480734
[TBL] [Abstract][Full Text] [Related]
4. Use of contrast in MR imaging of the lumbar spine.
Bradley WG
Magn Reson Imaging Clin N Am; 1999 Aug; 7(3):439-57, vii. PubMed ID: 10494528
[TBL] [Abstract][Full Text] [Related]
5. Nerve root enhancement on spinal MRI in pediatric Guillain-Barré syndrome.
Mulkey SB; Glasier CM; El-Nabbout B; Walters WD; Ionita C; McCarthy MH; Sharp GB; Shbarou RM
Pediatr Neurol; 2010 Oct; 43(4):263-9. PubMed ID: 20837305
[TBL] [Abstract][Full Text] [Related]
6. [Late intramedullary metastases of a medulloblastoma with primary extramedullary seeded metastases--magnetic resonance tomographic detection using gadolinium-DTPA].
Glathe S; Zanella FE; Abdallah A
Rontgenblatter; 1988 Dec; 41(12):484-7. PubMed ID: 3212363
[TBL] [Abstract][Full Text] [Related]
7. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: value of administering a high dose of contrast material.
Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
AJR Am J Roentgenol; 1994 Feb; 162(2):431-5. PubMed ID: 8310940
[TBL] [Abstract][Full Text] [Related]
8. Gd-DTPA-enhanced MR imaging of spinal tumors.
Parizel PM; Balériaux D; Rodesch G; Segebarth C; Lalmand B; Christophe C; Lemort M; Haesendonck P; Niendorf HP; Flament-Durand J
AJR Am J Roentgenol; 1989 May; 152(5):1087-96. PubMed ID: 2705343
[TBL] [Abstract][Full Text] [Related]
9. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
Yuh WT; Fisher DJ; Engelken JD; Greene GM; Sato Y; Ryals TJ; Crain MR; Ehrhardt JC
Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
Carvlin MJ; De Simone DN; Meeks MJ
Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
[TBL] [Abstract][Full Text] [Related]
12. Contrast enhancement in spinal MR imaging.
Breger RK; Williams AL; Daniels DL; Czervionke LF; Mark LP; Haughton VM; Papke RA; Coffer M
AJR Am J Roentgenol; 1989 Aug; 153(2):387-91. PubMed ID: 2750625
[TBL] [Abstract][Full Text] [Related]
13. Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast.
Petersein J; Saini S; Mitchell DG; Davis PL; Johnson CD; Kuhlman JE; Parisky YR; Runge VM; Weinreb J; Bernardino ME
AJR Am J Roentgenol; 1995 Nov; 165(5):1157-61. PubMed ID: 7572495
[TBL] [Abstract][Full Text] [Related]
14. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
[TBL] [Abstract][Full Text] [Related]
15. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
Powers TA; Partain CL; Kessler RM; Freeman MW; Robertson RH; Wyatt SH; Whelan HT
Radiology; 1988 Dec; 169(3):723-6. PubMed ID: 3055036
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of gadoteridol for magnetic resonance imaging of the brain and spine.
Runge VM; Bronen RA; Davis KR
Invest Radiol; 1992 Aug; 27 Suppl 1():S22-32. PubMed ID: 1506150
[TBL] [Abstract][Full Text] [Related]
18. [Experience in clinical use of paramagnetic agent magnevist in the diagnosis of spine and spinal cord metastases].
Gunicheva NV; Akhadov TA; Grakova LS; Batukhtin EN
Vestn Rentgenol Radiol; 1996; (6):15-8. PubMed ID: 9027071
[TBL] [Abstract][Full Text] [Related]
19. Spinal cord pial metastases: MR imaging with gadopentetate dimeglumine.
Lim V; Sobel DF; Zyroff J
AJR Am J Roentgenol; 1990 Nov; 155(5):1077-84. PubMed ID: 2120938
[TBL] [Abstract][Full Text] [Related]
20. Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents.
Suzuki H; Teranishi M; Sone M; Yamazaki M; Naganawa S; Nakashima T
Acta Otolaryngol; 2011 Oct; 131(10):1025-31. PubMed ID: 21732744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
